-
Jazz Pharma To Evaluate If Generic Xyrem's FDA Waiver Meets Required Legal Conditions
Wednesday, January 18, 2017 - 2:23pm | 500Jazz Pharmaceuticals plc - Ordinary Shares (NASDAQ: JAZZ) have been on a volatile ride. The Move At time of writing, the company's shares were rallying over 11 percent on roughly 2.6 times the average volume on Wednesday. This represented a reversal in sentiment from the move in after-hours...